CASE REPORT
|
doi:10.20944/preprints202104.0780.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Hereditary Leyomiomatosis and Renal Cell Cancer; Pembrolizumab; Axitinib
Online: 29 April 2021 (15:38:30 CEST)